JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 19 No. 7 810-815
© 1978 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kulkarni, P. V.
Right arrow Articles by Willerson, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kulkarni, P. V.
Right arrow Articles by Willerson, J. T.

Technetium-Labeled Heparin: Preliminary Report of a New Radiopharmaceutical with Potential for Imaging Damaged Coronary Arteries and Myocardium

Padmakar V. Kulkarni, Robert W. Parkey, L. Maximilian Buja, James E. Wilson, III, Frederick J. Bonte and James T. Willerson

University of Texas Health Science Center at Dallas, Dallas, Texas

Correspondence: For reprints contact: Ischemic Heart Center, L5-134, The University of Texas Health Science Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75235.

ABSTRACT

Heparin has been labeled with [99mTc] pertechnetate and its ability to image damaged coronary vessels and myocardium during and following myocardial ischemia has been studied in experimental animals. The data obtained indicate that Tc-99m heparin localizes in damaged myocardium and coronary vessels in canine models of temporary myocardial ischemia and reperfusion and in damaged myocardium during fixed coronary occlusion. Scintigraphic detection of damaged myocardium was possible in both models, but the highest levels of Tc-99m heparin in damaged myocardial tissue were found in those dogs with temporary coronary occlusion and reflow. The data suggest that Tc-99m heparin may be of value as a positive imaging agent when coronary arteries or myocardium are injured and either reperfusion is allowed and/or significant blood flow persists in the damaged area.




This article has been cited by other articles:


Home page
CirculationHome page
E. Camenzind, W. H. Bakker, A. Reijs, I. M. van Geijlswijk, E. Boersma, M. J. B. Kutryk, E. P. Krenning, J. R. T. C. Roelandt, P. W. Serruys, and P. W. Serruys
Site-Specific Intracoronary Heparin Delivery in Humans After Balloon Angioplasty : A Radioisotopic Assessment of Regional Pharmacokinetics
Circulation, July 1, 1997; 96(1): 154 - 165.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1978 by the Society of Nuclear Medicine.